Prevention and Control of Chronic Disease and Associated Risk Factors in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and P. R.

Active

Assistance listing
93.377
Agency
Grant awards
44 $425,962,512 in federal obligations

Program facts

Assistance type
  • Cooperative Agreement
Treasury account
  • 75-0943-0-1-550

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The Centers for Disease Control and Prevention (CDC) is funding public health programs to prevent and control chronic disease in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and Puerto Rico under Assistance Listing 93.377, with the most recent grant awards issued September 30, 2026.

This program funds evidence-based strategies addressing tobacco use and secondhand smoke exposure, diabetes prevention and management, cardiovascular disease prevention and management, oral health, and maternal and child health in American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, the U.S. Virgin Islands, and Puerto Rico. The program recognizes the unique challenges these jurisdictions face—widely dispersed small populations, small workforces, geographic remoteness, over-burdened health systems managing both communicable and non-communicable diseases, and natural disaster vulnerability—and supports culturally tailored implementation strategies. Awards fund a five-year project period with 12-month budget cycles, conditioned on satisfactory progress and fund availability.

The portfolio consists entirely of Cooperative Agreements across 44 total awards spanning 2019 to 2026. The CDC National Center for Chronic Disease Prevention and Health Promotion dominates funding, accounting for 43 awards totaling $421 million in federal dollars obligated, with one additional award of $5 million. Combined federal and non-federal dollars obligated total $440.9 million. Award volume has been variable—16 awards in 2022, 5 in 2023, 14 in 2024, 1 in 2025, and 3 in 2026—indicating inconsistent annual cadence. Recent awards show typical magnitudes ranging from $443,904 to $17.9 million, though most cluster in the low-to-mid single millions. Representative 2026 awards funded prostate cancer screening survey validation and implementation research (three awards, $443,904 to $449,436 each). Prior 2024 awards supported young breast cancer survivor support networks ($1.38 to $2.76 million each) and cancer prevention research initiatives.

A new solicitation, CDC-RFA-DP-25-0024, posted July 23, 2024, with application due January 15, 2025, seeks proposals for chronic disease prevention in U.S. territories and freely associated states through a required Core Component and optional Oral Health Component addressing tobacco, diabetes, and oral health disparities. Applicants must demonstrate ability to serve one of the eight eligible jurisdictions and, if not a territorial government, must submit a memorandum of agreement with the relevant Department/Ministry of Health. The prior opportunity (CDC-RFA-DP19-1901, posted November 2018, due January 2019) capped individual awards at $1.4 million.

Objective and description

Objective

The purpose of this five-year program is to reduce the rates of disability and death associated with chronic disease in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and Puerto Rico. The U.S. Affiliated Pacific Islands include American S

Description

This program will support public health programs to prevent and control chronic disease and associated risk factors in American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau, U.S. Virgin Islands, and Puerto Rico. In recognition of their unique challenges and needs including widely dispersed small populations, small workforce, geographically remote locations, over-burdened health systems addressing both non-communicable diseases and infectious disease outbreaks, and natural disasters, this program will support the implementation of strategies in the four domains of chronic disease prevention that are adapted to be culturally relevant and appropriate. It supports evidence-based strategies to reduce tobacco use and secondhand smoke exposure, prevent and improve management of diabetes and CVD, improve availability and quality of data to inform chronic disease programs, including maternal and child and oral health, and monitor health trends and progress.

Eligibility

Applicant eligibility

Applicants must provide proof of ability to serve populations in one of the following jurisdictions: Commonwealth of the Northern Mariana Islands (CNMI), American Samoa, Guam, Federated States of Micronesia (FSM), Republic of the Marshall Islands (RMI), Republic of Palau, U.S. Virgin Islands, Puerto Rico

Beneficiary eligibility

Northern Mariana Islands, American Samoa, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau, U.S. Virgin Islands, Puerto Rico.

Uses of assistance

Funds can be used to pay overhead, travel costs, and other expenses directly related to achievement of the strategies and activities identified to fulfill the obligations specified in the notice of funding. Funds can be used for salaries for personnel to plan, implement, monitor, and evaluate program activities; for contracts or agreements to implement and evaluate program activities, including assessments and convening coalitions; contracts or agreements with community-based organizations or coalitions to provide health education and lifestyle support programs, or to improve the health of the physical environment (for example to improve access to healthy food, physical activity, or decrease tobacco exposure); or other activities that promote or support healthy behaviors and improved health in the population. Funds can be used to pay for activities and supplies necessary to provide the services outlined here, including self-blood pressure monitoring equipment. Funds can be used to develop and maintain data collection systems to collect and report biomeasures and behavior information and for monitoring systems for chronic disease.

Length and time phasing of assistance

Financial assistance is provided for a 12-month budget period with project periods of up to five years subject to the availability of funds and satisfactory progress of the recipient.

How to apply

Criteria for selecting proposals

Phase I: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Applicants must provide proof of ability to serve populations in American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau, U.S. Virgin Islands, or Puerto Rico. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components - Core Component and Competitive Components. Core Component: The Core Component will support recipients to implement the strategies and activities as outline in the NOFO. Applicants must propose a comprehensive work plan that addresses the activities following broad Strategies indicated in the NOFO. Applicants for the Core Component will be evaluated based on the evaluation criteria as indicated in the NOFO. Competitive Components: This program has two competitive Component that will support maternal and child health and oral health activities. All applicants must apply for the Core Component in order to be considered for either (or both) of the Competitive Components. Only those successful applicants under the Core Component will be eligible for Competitive Component funding. Applicants must apply for competitive Component funding at the same time they make application for Core Component funding. Competitive components will be evaluated based on the evaluation criteria as indicated in the NOFO. Phase III Review: Applications submitted under the Core Component will be funded by score and rank as determined by the objective review panel. Applications submitted under the Competitive Component will be funded by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards.

Award procedure

After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public.

Deadlines

Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.

Renewals

The project period is 5-years with 12-month budget periods. Throughout the project period, CDC's commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports, in documented technical assistance, and in other relevant documented activities), and the determination that continued funding is in the best interest of the federal government.

Grant opportunities

Grant awards

Award Recipient Federal obligations Awarded
Optimal survey questions for prostate cancer screening and shared decision-making U48DP006952 New York University $443,904
Testing the accuracy, reliability, and utility of survey tools for PSA screening and shared decision-making… U48DP006939 University Of North Carolina At Chapel Hill $449,436
Developing and evaluating computable phenotypes to identify active surveillance in prostate cancer using electronic… U48DP006936 University Of Massachusetts Medical School $399,303
SWW-impacts: scaling what works -improving and accelerating cancer prevention, treatment, and survivorship U48DP006953 University Of North Carolina At Chapel Hill $1,955,852
Untold: understanding the experience of ovarian cancer - life after diagnosis: a mixed methods approach U48DP006876 Regents Of The University Of Minnesota $850,000
Digital health implementation strategies to improve lung cancer screening among safety-net clinics U48DP006855 University Of Utah $1,549,990
NYU-cuny prevention research center - revision - 5- 24-003 U48DP006848 New York University $1,849,973
Supporting young breast cancer survivors, metastatic breast cancer patients, and their families NU58DP007917 National Association Of Chronic Disease Directors, Inc. $1,380,000
Bridging gaps and transforming care for young breast cancer survivors and those with metastatic disease NU58DP007916 Weill Medical College Of Cornell University $1,380,000
Supporting young breast cancer survivors, metastatic breast cancer patients, and their families NU58DP007915 Sharsheret $1,380,000

Latest 10 of 44 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 40 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $14,320,938
FY2025 $16,570,278
FY2024 $5,259,555
FY2023 $3,524,308
FY2022 $5,732,271
FY2021 $3,283,508
FY2020 $7,220,186
FY2019 $2,418,062

Quick answers

What is Assistance Listing 93.377?

Assistance Listing 93.377 is Prevention and Control of Chronic Disease and Associated Risk Factors in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and P. R., a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).

What is the CFDA number for Prevention and Control of Chronic Disease and Associated Risk Factors in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and P. R.?

Its CFDA number is 93.377: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.377 awarded?

44 grant awards under 93.377 have obligated $425,962,512 in federal funds to 40 recipients.

Who receives the most funding from 93.377?

The recipients obligated the most under Prevention and Control of Chronic Disease and Associated Risk Factors in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and P. R. are Health Research, Inc. ($72,131,824), Washington State Department Of Health ($46,298,664) and Utah Department Of Health And Human Services ($43,144,052).

How much did 93.377 obligate in fiscal year 2025?

Grants under 93.377 obligated $16,570,278 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.377?

No opportunity listed under 93.377 is open now. The latest, Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States, was posted on July 23, 2024.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program